All Stories

  1. Brain Connectivity Gradients Alterations in Discordant Cerebrospinal Fluid Profile for Alzheimer's Disease Biomarkers
  2. Medical risk factors, ApoE haplotype, and Alzheimer’s disease: a large-scale analysis
  3. Tense production in French-speaking participants with Alzheimer's disease: What about discourse? Contribution of a storytelling-in-sequence task
  4. Linking Personality Traits to Disability Progression in Multiple Sclerosis: A Longitudinal Analysis
  5. Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilities
  6. Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer Disease: Intersocietal Recommendations for Their Appropriate Use in Switzerland
  7. Biomarkers do not paint the whole picture: The role of clinical expertise and advanced neuroimaging for Alzheimer's disease diagnosis
  8. Association of Motoric Cognitive Risk Syndrome and High C-Reactive Protein Serum Levels With Incident Major Neurocognitive Disorder: Results From the Quebec NuAge Cohort
  9. Can brain network connectivity facilitate the clinical development of disease-modifying anti-Alzheimer drugs?
  10. Anti-Amyloid Drugs for Alzheimer’s Disease: Considering the Role of Depression
  11. Functional dynamic network connectivity differentiates biological patterns in the Alzheimer's disease continuum
  12. Reader Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging
  13. Normal pressure hydrocephalus and cognitive impairment: The gait phenotype matters too
  14. Markers of limbic system damage following SARS-CoV-2 infection
  15. Impact of Subjective Evaluations in Predicting Response to Ventriculoperitoneal Shunt for Idiopathic Normal Pressure Hydrocephalus
  16. Long COVID Neuropsychological Deficits after Severe, Moderate, or Mild Infection
  17. Functional connectivity underlying cognitive and psychiatric symptoms in post-COVID-19 syndrome: is anosognosia a key determinant?
  18. Gait stability in ambulant children with cerebral palsy during dual tasks
  19. The Two-Way Route between Delirium Disorder and Dementia: Insights from COVID-19
  20. “Emergency Room Evaluation and Recommendations” and Incident Hospital Admissions in Older People with Major Neurocognitive Disorders Visiting Emergency Department: Results of an Experimental Study
  21. Decrease in pain perception during acute SARS-CoV-2 infection: a case series
  22. COVID-19 associated stroke and cerebral endotheliitis
  23. COVID‐19 encephalopathy: Clinical and neurobiological features
  24. Beyond silent hypoxemia: Does COVID‐19 can blunt pain perception? Comment on “The neuroinvasive potential of SARS CoV2 may play a role in the respiratory failure of COVID 19 patients”
  25. Normal pressure hydrocephalus and CSF tap test response: the gait phenotype matters
  26. Dyspnea: The vanished warning symptom of COVID‐19 pneumonia
  27. Smoothness of Gait in Healthy and Cognitively Impaired Individuals: A Study on Italian Elderly Using Wearable Inertial Sensor
  28. Commentary: Prevalence of Alternative Diagnoses and Implications for Management in Idiopathic Normal Pressure Hydrocephalus Patients
  29. Motoric cognitive risk syndrome and incident dementia: results from a population‐based prospective and observational cohort study
  30. Structural Brain Volume Covariance Associated with Gait Speed in Patients with Amnestic and Non-Amnestic Mild Cognitive Impairment: A Double Dissociation
  31. Deconstructing or reestablishing frontal gait in normal pressure hydrocephalus?
  32. Is frontal gait a myth in normal pressure hydrocephalus?
  33. Motoric cognitive risk syndrome and mortality: results from the EPIDOS cohort
  34. The relationship between depression, anxiety and cognition and its paradoxical impact on falls in multiple sclerosis patients
  35. Dopaminergic imaging separates normal pressure hydrocephalus from its mimics
  36. Brain comorbidities in normal pressure hydrocephalus
  37. Neural correlates of gait variability in people with multiple sclerosis with fall history
  38. Parkinsonism is a Phenotypical Signature of Amyloidopathy in Patients with Gait Disorders
  39. Spatiotemporal Gait Characteristics Associated with Cognitive Impairment: A Multicenter Cross-Sectional Study, the Intercontinental "Gait, cOgnitiOn & Decline" Initiative
  40. Brain comorbidities in normal pressure hydrocephalus
  41. Apathy in idiopathic normal pressure hydrocephalus: A marker of reversible gait disorders
  42. Gait stability in patients treated by fingolimod: A longitudinal pilot study on 9 patients with multiple sclerosis
  43. Does fear of falling predict gait variability in multiple sclerosis?
  44. CSF tapping also improves mental imagery of gait in normal pressure hydrocephalus
  45. Gait variability at fast-pace walking speed: A biomarker of mild cognitive impairment?
  46. Erratum
  47. The influence of individual motor imagery ability on cerebral recruitment during gait imagery
  48. Contribution of Brain Imaging to the Understanding Of Gait Disorders in Alzheimer’s Disease
  49. Derivation and validation of a Short Form of the Mini-Mental State Examination for the screening of dementia in older adults with a memory complaint
  50. Gait and motor imagery of gait in early schizophrenia
  51. Effects of amygdala–hippocampal stimulation on interictal epileptic discharges
  52. Vitamin D insufficiency and mild cognitive impairment: cross-sectional association
  53. Adapted Timed Up and Go: A Rapid Clinical Test to Assess Gait and Cognition in Multiple Sclerosis
  54. Gait control: a specific subdomain of executive function?
  55. Does Memantine Improve the Gait of Individuals with Alzheimer's Disease?
  56. Development of a short form of Mini-Mental State Examination for the screening of dementia in older adults with a memory complaint: a case control study
  57. Association Between High Variability of Gait Speed and Mild Cognitive Impairment: A Cross-Sectional Pilot Study
  58. Timed up and go test and risk of falls in older adults: A systematic review
  59. Biology of gait control: Vitamin D involvement
  60. Test-retest reliability of stride time variability while dual tasking in healthy and demented adults with frontotemporal degeneration
  61. Poor creativity in frontotemporal dementia: A window into the neural bases of the creative mind
  62. Interest of dual-task-related gait changes in idiopathic normal pressure hydrocephalus
  63. Decrease in gait variability while counting backward: a marker of “magnet effect”?
  64. Imagined Timed Up & Go test: A new tool to assess higher-level gait and balance disorders in older adults?
  65. EFFECT OF PSYCHOACTIVE MEDICATION ON GAIT VARIABILITY IN COMMUNITY-DWELLING OLDER ADULTS: A CROSS-SECTIONAL STUDY
  66. Antiepileptic drugs modify power of high EEG frequencies and their neural generators
  67. Frontotemporal dementia: Pathology of gait?
  68. Vitamin D and cognitive performance in adults: a systematic review
  69. Association of vitamin D deficiency with cognitive impairment in older women: Cross-sectional study
  70. Stops walking when talking: a predictor of falls in older adults?
  71. Gait Variability among Healthy Adults: Low and High Stride-to-Stride Variability Are Both a Reflection of Gait Stability
  72. Walking speed-related changes in stride time variability: effects of decreased speed
  73. Frontal Assessment Battery is a marker of dorsolateral and medial frontal functions: A SPECT study in frontotemporal dementia
  74. Recurrent Falls and Dual Task–Related Decrease in Walking Speed: Is There a Relationship?
  75. GALANTAMINE IMPROVES GAIT PERFORMANCE IN PATIENTS WITH ALZHEIMER'S DISEASE
  76. Concurrent validity of SMTEC® footswitches system for the measurement of temporal gait parameters
  77. Does Change in Gait while Counting Backward Predict the Occurrence of a First Fall in Older Adults?
  78. Dual Task–Related Changes in Gait Performance in Older Adults: A New Way of Predicting Recurrent Falls?
  79. Impact of Impaired Executive Function on Gait Stability
  80. Changes in gait while backward counting in demented older adults with frontal lobe dysfunction
  81. Mild clinical expression of Lambert Eaton myasthenic syndrome in a patient with HIV infection
  82. 'Faster counting while walking' as a predictor of falls in older adults
  83. Is low lower-limb kinematic variability always an index of stability?
  84. Myasthenia gravis associated with HTLV-I infection and atypical brain lesions
  85. LONG-TERM PRACTICE OF JAQUES-DALCROZE EURHYTHMICS PREVENTS AGE-RELATED INCREASE OF GAIT VARIABILITY UNDER A DUAL TASK